Huimin Cheng

Rationally designed BCL6 inhibitors target activated B cell diffuse large B cell lymphoma

Mariano Cárdenas, Wenbo Yu, Wendy Béguelin et al. · Journal of Clinical Investigation · 2016 · 172 citations · Full text

Medicine, Oncology, Pharmacology +17

Inhibition of HSP90β Improves Lipid Disorders by Promoting Mature SREBPs Degradation via the Ubiquitin-proteasome System

Zu‐Guo Zheng, Xin Zhang, Xiao-Xiao Liu et al. · Theranostics · 2019 · 84 citations · Full text

Life Sciences, Biochemistry, Pharmacology +12

Red yeast rice ameliorates high-fat diet-induced atherosclerosis in <i>Apoe</i>^−/− mice in association with improved inflammation and altered gut microbiota composition

Yanhan Dong, Huimin Cheng, Ying Liu et al. · Food & Function · 2019 · 63 citations · Full text

Life Sciences, Nutrition, Nutritional Sciences +17

Dual targeting of SREBP2 and ERRα by carnosic acid suppresses RANKL-mediated osteoclastogenesis and prevents ovariectomy-induced bone loss

Zu‐Guo Zheng, Huimin Cheng, Yaping Zhou et al. · Cell Death and Differentiation · 2020 · 57 citations · Full text

Medicine, Cell Biology, Molecular Biology +17

Identification of Thiourea-Based Inhibitors of the B-Cell Lymphoma 6 BTB Domain via NMR-Based Fragment Screening and Computer-Aided Drug Design

Huimin Cheng, Brian M. Linhares, Wenbo Yu et al. · Journal of Medicinal Chemistry · 2018 · 44 citations · Full text

Pharmacy, Medicinal Chemistry, Oncology +14